Document is current
Any future updates will be listed below
-
Authors
Toren, Paul https://orcid.org/0000-0002-5762-5787
Brisson, Hervé
Simonyan, David
Hovington, Hélène
Lacombe, Louis
Bergeron, Alain
Fradet, Yves
-
Funding
Funding for this research was provided by:
Astellas Pharma Canada
Fonds de Recherche du Québec - Santé (32774)
- License Information
-
More Information
Article History
Received: 4 April 2020
Accepted: 8 July 2020
First Online: 16 July 2020
Compliance with ethical standards
:
: AB reports research funding from Astellas, IMV Inc, GSK biologicals as well as personal fees as a consultant from Merck. YF reports research funding from Tersera, Astellas, IMV Inc., as well as personal fees as a consultant from Merck, Sanofi, Ferring, Amgen, Janssen, Astellas. PT reports research funding from Bristol-Myers-Squibb, Sanofi and Janssen as well as personal fees as a consultant from TerSera, Janssen, Sanofi, and Abbvie. The other authors have no conflicts of interest to declare.
: Ethics approval for this study was obtained from the Centre Hospitalier Universitaire de Québec-Université Laval (#2016–2433).
: Informed written consent was obtained from all patients included in the study.
